Clinical Trial Update: The Safety/Efficacy of Rifaximin With/Without Lactulose in Participants With A History of Recurrent Hepatic Encephalopathy [Phase 4]

View source ↗

Summary

Phase 4 trial assessing safety and efficacy of rifaximin with or without lactulose in participants with a history of recurrent hepatic encephalopathy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cirrhosis
• Hepatic Encephalopathy

Drugs mentioned

• LACTULOSE (Lactulose)
• Rifaximin (rifaximin)

Snippet

Sponsor: Bausch Health Americas, Inc. | Conditions: Hepatic Encephalopathy, Cirrhosis | Phase 4 | Status: COMPLETED | Results posted: 2019-09-09